Pes cavus pathogenesis in Charcot-Marie-Tooth disease type 1A [3]

Brain

Volumn 129, Issue 7, 2006, Pages

  Burns, Joshua ^a   Ouvrier, Robert ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT MALFORMATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEG MUSCLE; LETTER; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PES CAVUS; PRIORITY JOURNAL; WALKING;

CHARCOT-MARIE-TOOTH DISEASE; FOOT; FOOT DEFORMITIES; HUMANS; MUSCLE, SKELETAL;

EID: 33745699839     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl116     Document Type: Letter

References (16)

1. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997; 120: 813-23.
2. Burns J, Redmond A, Crosbie J, Ouvrier R. Quantification of muscle strength and imbalance in neurogenic pes cavus, compared to health controls, using hand-held dynamometry. Foot Ankle Int 2005; 26: 540-44.
3. Escolar DM, Henricson EK, Mayhew J, Florence J, Leshner R, Patel KM, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001; 24: 787-93.
4. Gallardo E, Garcia A, Combarros O, Berciano J. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 2006; 129: 426-37.
5. Holmes JR, Hansen ST Jr. Foot and ankle manifestations of Charcot-Marie-Tooth disease. Foot Ankle Int 1993; 14: 476-86.
6. Kilmer DD, Aitkens SG, Wright NC, McCrory MA. Simulated work performance tasks in persons with neuropathic and myopathic weakness. Arch Phys Med Rehabil 2000; 81: 938-43.
7. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123: 1516-27.
8. Mann DC, Hsu JD. Triple arthrodesis in the treatment of fixed cavovarus deformity in adolescent patients with Charcot-Marie-Tooth disease. Foot Ankle 1992; 13: 1-6.
9. Mann RA, Missirian J. Pathophysiology of Charcot-Marie-Tooth disease. Clin Orthop Relat Res 1988; 234: 221-8.
10. Moseley AM, Crosbie J, Adams R. Normative data for passive ankle plantarflexion - dorsiflexion flexibility. Clin Biomech 2001; 16: 514-21.
11. O'Brien MD. Aids to the examination of the peripheral nervous system. Edinburgh: W.B. Saunders [on behalf of the Guarantors of Brain]; 2000.
12. Price AE, Maisel R, Drennan JC. Computed tomographic analysis of pes cavus. J Pediatr Orthop 1993; 13: 646-53.
13. Sabir M, Lyttle D. Pathogenesis of pes cavus in Charcot-Marie-Tooth disease. Clin Orthop Relat Res 1983; 175: 173-8.
14. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997; 120: 465-78.
15. Tynan MC, Klenerman L, Helliwell TR, Edwards RH, Hayward M. Investigation of muscle imbalance in the leg in symptomatic forefoot pes cavus: a multidisciplinary study. Foot Ankle 1992; 13: 489-501.
16. Verhamme C, van Schaik IN, Koelman JHTM, de Haan RJ, Vermeulen M, de Visser M. Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy 1A. J Neurol 2004; 251: 1491-7.